As of 2025-09-16, the Relative Valuation of THC Biomed Intl Ltd (THC.CN) is (0.15) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of THC Biomed Intl Ltd based on Relative Valuation is -861.4%.
The range of the Relative Valuation is (0.12) - (0.16) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.6x - 3.6x | 3.4x |
| Forward P/E multiples | 2.6x - 4.4x | 3.4x |
| Fair Price | (0.12) - (0.16) | (0.15) |
| Upside | -682.3% - -897.3% | -861.4% |
| Date | P/E |